NewAmsterdam Pharma (NAMS) Cash from Financing Activities (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported Cash from Financing Activities of $11.04 million for Q2 2026, up 222.4% from $3.43 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, NewAmsterdam Pharma's Cash from Financing Activities came in at $41.68 million, down 91.1% year-over-year; for FY2025, it came in at $29.52 million, down 95.5% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $659.51 million in FY2024, $8.91 million in FY2023 (-97.7%), $391.91 million in FY2022 (+362.7%) and $84.7 million in FY2021 (+555.4%).
- Five-year quarterly Cash from Financing Activities spans a low of $58,000 in Q3 2024 and a high of $456.61 million in Q4 2024.
- Year over year, Cash from Financing Activities gained in two of the last six quarters, with growth averaging 0.5%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.07 million (Q1 2026), $13.68 million (Q4 2025) and $5.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | 11.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.04 Mn |
| Mar 31, 2026 | 11.07 Mn |
| Dec 31, 2025 | 13.68 Mn |
| Sep 30, 2025 | 5.89 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 6.52 Mn |
| Dec 31, 2024 | 456.61 Mn |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 198.18 Mn |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | 6.33 Mn |
| Mar 31, 2023 | 2.39 Mn |
API Access
NewAmsterdam Pharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();